Interview with Stefany Shaheen: Revolutionizing diabetes care through cell therapies

I had the extraordinary opportunity to chat with Stefany Shaheen, the Chief Strategy Officer of Advanced Regenerative Manufacturing Institute (ARMI) and BioFab USA, about the transformative potential of cell therapies for individuals living with diabetes. Stefany shared her remarkable journey, insights on cell therapies’ current status, approval challenges, and how the diabetes community can contribute to advancing research in this field. A few months before this discussion with Stefany, I had the opportunity to hear Dean Kamen speak at the recent DiabetesMine Innovation Summit in November. Dean is a remarkable person with a track record of innovation. There is a terrific video on the BioFabUSA site that I encourage you to watch. Head to their website and click on the “Watch Video” button. Following my experience with Dean, it was fun for me to talk with Stefany. Stefany Shaheen's Inspiring Journey Stefany’s background is nothing short of awe-inspiring. A mother of four, including her eldest daughter Elle, who lives with diabetes, Stefany is a graduate of MIT’s Sloan School of Management and Harvard’s Kennedy School of Government. She is a New York Times best...
Source: Scott's Diabetes Blog - Category: Endocrinology Authors: Tags: Blog Posts Source Type: blogs